Barriers to delivery of macromolecules

Medicinal Chemistry Research

Volumn 7, Issue 9, 1997, Pages 493-508

  Topp, Elizabeth M ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0344731684     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. *1. Biological Barriers to Protein Delivery, K. L. Audus, K.L.; and T. J. Raub, T.J., Eds.; Plenum Press, NY, 1993; pp. 51-70.
2. Narawane, L.; Lee, V.H.L. In Drug Absorption Enhancement: Concepts, Possibilities, Limitations and Trends; de Boer, A.G., Ed., Harwood Academic Publishers, Langhorne, PA 1994; pp. 1-66.
3. Gruenberg, J.; Maxfield, F.R. Current Opinion in Cell Biol. 1995, 7, 552-563.
4. *4. Mellman, I. Annu. Rev. Cell Dev. Biol. 1996, 12, 575-625.
5. van Deurs, B.; Hansen, S.H.; Olsnes, S.; Sandvig, K. In Biological Barriers to Protein Delivery; Audus, K.L.; T. J. Raub, T.J., Eds., Plenum Press, NY, 1993; pp. 71-104.
6. Subtil, A.; Delepierre, M.; Dautry-Varsat, A. J. Cell Biol. 1997, 136, 583-595.
7. Medesan, C.; Matesoi, D.; Radu, C.; Ghetie, V.; Ward, E.S. J. Immunol. 1997, 158, 2211-2217.
8. Loman, S.; Radl, J.; Jansen, H.M.; Out, T.A.; Lutter, R. Am. J. Physiol. 1997, 272, L951-L958.
9. *9. Lutz, K.L.; Siahaan, T.J. J. Pharm. Sci. 1997, 86, 977-984.
10. Hirase, T.; Staddon, J.M.; Saitou, M.; Ando-Akatsuka, Y.; Itoh, M.; Furuse, M.; Fujimoto, K.; Tsukita, S.; Rubin, L.L. J. Cell Sci. 1997, 110, 1603-1613.
11. McCarthy, K.M.; Skare, I.B.; Stankewich, M.C.; Furuse, M.; Tsukita, S.; Rogers, R.A.; Lynch, R.D.; Schneeberger, E.E. J. Cell Sci. 1996, 109, 2287-2298.
12. Balda, M.S.; Whitney, J.A.; Flores, C.; González, S.; Cereijido, M.; Matter, K. J. Cell Biol. 1996, 134, 1031-1049.
13. Schulze, C.; Smales, C.; Rubin, L.L.; Staddon, J.M. J. Neurochem. 1997, 68, 991-1000.
14. Lutz, K.L.; Bogdanowich-Knipp, S.; Pal, D.; Siahaan, T.J. Current Topics Peptide Protein Res., in press.
15. *15. Khasigov, P.Z.; Khasanbaeva, G.Sh.; Rubachev, P.G.; Nikolaev, A. Ya.; Grachev, S.V. Biochemistry (Moscow) 1996, 61, 825-836.
16. Yurchenco, P.D. Ann. N. Y. Acad. Sci. 1990, 580, 195-213.
17. *17. Yurchenco, P.D.; O'Rear, J. In Molecular and Cellular Aspects of Basement Membranes; Rohrbach, D.; Timpl, R., Eds., Academic Press, NY, 1993; pp. 19-47.
18. Haskin, C.L.; Cameron, I.L.; Rohrbach, D.H. In Molecular and Cellular Aspects of Basement Membranes; Rohrbach, D.; Timpl, R., Eds., Academic Press, NY, 1993; pp. 107-117.
19. Katz, M.A.; Barrette, T.; Krasovich, M. Am. J. Physiol. 1992, 263, H1417-H1421.
20. Lin, C.Q.; Bissell, M.J. FASEB J. 1993, 7, 737-743.
21. *21. Lightfoot, E.N. In The Biomedical Engineering Handbook; Bronzino, J.D., Ed.; CRC Press, Boca Raton, FL, 1995; pp. 1656-1670.
22. *22. Jain, R.K. Sci. Am. 1994 (July), 277, 58-65.
23. Fujimori, K.; Covell, D.G.; Fletcher, J.E.; Weinstein, J.N. J. Nuclear Med. 1990, 31, 1191-1198.
24. Juweid, M.; Neumann, R.; Paik, C.; Peres-Bacete, M.J.; Sato, J.; van Osdol, W.; Weinstein, J.N. Cancer Res. 1993, 55, 2092-2099.
25. Baxter, L.T.; Jain, R.K. Microvascular Res. 1989, 57, 77-104.
26. Baxter, L.T.; Jain, R.K. Microvascular Res. 1990, 40, 246-263.
27. Baxter, L.T.; Jain, R.K. Microvascular Res. 1991, 41, 5-23.
28. Baxter, L.T.; Jain, R.K. Microvascular Res. 1991, 41, 252-272.
29. Vijaykumar, V.; Topp, E.M. Pharm. Res. 1995, 12, 1907-1916.
30. Rippley, R.K.; Stokes, C.J. Biophys. J. 1995, 69, 825-839.
31. *31. Stability of Protein Pharmaceuticals. Part A: Chemical and Physical Pathways of Protein Degradation; Ahern, T.J.; Manning, M.C., Eds.; Plenum Press, NY, 1992.
32. *32. Stability of Protein Pharmaceuticals. Part B: In Vivo Pathways of Degradation and Strategies fo Protein Stabilization; Ahern, T.J.; Manning, M.C., Eds.; Plenum Press, NY, 1992.
33. Mammalian Ectoenzymes, Kenny, A.J.; Turner, A.J., Eds.; Elsevier, NY, 1987.
34. Woodley, J.F. Crit. Revs. Therapeutic Drug Carrier Systems 1994, 11, 61-95.
35. Clarke, S.; Stephenson, R.C.; Lowenson, J.D. In Stability of Protein Pharmaceuticals. Part A: Chemical and Physical Pathways of Protein Degradation; Ahern, T.J.; Manning, M.C., Eds.; Plenum Press, NY, 1992; pp. 1-29.
36. Oliyai, C.; Borchardt, R.T. In Formulation and Delivery of Proteins and Peptides, J. L. Cleland, J.L.; and R. Langer, R., Eds.; American Chemical Society, Washington, DC, 1994. pp. 46-58.
37. Li, S.; Schöneich, C.; Wilson, G.S.; Borchardt, R.T. Pharm. Res. 1993, 10, 1572-1579.
38. Kosen, P.A. In Stability of Protein Pharmaceuticals. Part A: Chemical and Physical Pathways of Protein Degradation; Ahern, T.J.; Manning, M.C., Eds.; Plenum Press, NY, 1992; pp. 31-67.
39. Costantino, H.R.; Langer, R.; Klibanov, A.M. Pharm. Res., 1994, 11, 21-29.
40. *40. Brockman, S.A.; Murphy, R.F. In Biological Barriers to Protein Delivery, K. L. Audus, K.L.; and T. J. Raub, T.J., Eds.; Plenum Press, NY, 1993; pp. 51-70.
41. *41. Benjamini, E.; and Leskowitz, S. Immunology: A Short Course, 2nd Ed.; Wiley-Liss, NY, 1991; pp. 173-192.
42. *42. Konrad, M.W. In Biological Barriers to Protein Delivery, K. L. Audus, K.L.; and T. J. Raub, T.J., Eds.; Plenum Press, NY, 1993; pp. 409-437.
43. Lauffenberger, D.A.; Linderman, J.J. Receptors: Models for Binding, Trafficking and Signaling; Oxford University Press, NY, 1993; pp. 1-8, 73-78.